FDA approves Freenome's blood-based colorectal cancer screening test

July 27, 2026 8:00 AM

Freenome (Nasdaq: FRNM) and Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration has approved SimpleScreen CRC, a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found